(Q43889807)

27 November 2017

title

Plasma ascorbic acid: measurement, stability and clinical utility revisited (English)

1 reference

27 November 2017

Chung WY

1

1 reference

27 November 2017

Chung JK

2

1 reference

27 November 2017

Szeto YT

3

1 reference

27 November 2017

Tomlinson B

4

1 reference

27 November 2017

Benzie IF

5

1 reference

27 November 2017

publication date

1 November 2001

1 reference

27 November 2017

published in

Clinical Biochemistry

1 reference

27 November 2017

volume

34

1 reference

27 November 2017

issue

8

1 reference

27 November 2017

page(s)

623-627

1 reference

New data on vitamin C intake

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900270-3

Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900270-3

Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900270-3

Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900270-3

Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900270-3

Vitamin C: antioxidant or pro-oxidant in vivo?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900270-3

Ascorbic acid and dehydroascorbic acid analyses in biological samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900270-3

An automated, specific, spectrophotometric method for measuring ascorbic acid in plasma (EFTSA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900270-3

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900270-3

Simultaneous automated measurement of total 'antioxidant' (reducing) capacity and ascorbic acid concentration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900270-3

Statistical methods for assessing agreement between two methods of clinical measurement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900270-3

On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900270-3

Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900270-3

10.1016/S0009-9120(01)00270-3

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference